Veterinary Medicine Information website

Myorelax 100 mg/ml Oplossing voor infusie

Authorised
  • Guaifenesin

Product identification

Medicine name:
Myorelax 100 mg/ml Oplossing voor infusie
Active substance:
  • Guaifenesin
Target species:
  • Horse (pony)
  • Horse
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Guaifenesin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Horse (pony)
      • Milk
        no withdrawal period
      • Meat and offal
        no withdrawal period
    • Horse
      • Milk
        no withdrawal period
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM03BX90
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Myorelax 1 Vial with 500 ml Solution for infusion

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V116261
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 28/02/2026
German (PDF)
Published on: 28/02/2026
Dutch (PDF)
Published on: 28/02/2026

Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 28/02/2026
German (PDF)
Published on: 28/02/2026
Dutch (PDF)
Published on: 28/02/2026

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 28/02/2026
German (PDF)
Published on: 28/02/2026
Dutch (PDF)
Published on: 28/02/2026